Clinical trial
A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
NCT00936182 is registered in ClinicalTrials.gov with The Center for Autism and Related Disorders as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Study of the Efficacy of Fluconazole as a Treatment for Autism Spectrum Disorder
- Lead sponsor
- The Center for Autism and Related Disorders
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 31, 2009
- Completion date
- July 31, 2011
- Enrollment
- 50 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.